| Net Cash Provided by (Used in) Operating Activities |
$1,827,000 |
USD |
-130% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Financing Activities |
$223,000 |
USD |
|
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Investing Activities |
$34,000 |
USD |
|
Q1 2025 |
Q1 2025 |
| Common Stock, Shares Authorized |
225,000,000 |
shares |
29% |
Q3 2025 |
Q3 2025 |
| Common Stock, Shares, Issued |
120,394,000 |
shares |
25% |
Q3 2025 |
Q3 2025 |
| Common Stock, Par or Stated Value Per Share |
0.01 |
USD/shares |
0% |
Q3 2025 |
Q3 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
$1,638,000 |
USD |
-98% |
Q1 2025 |
Q1 2025 |
| Deferred Tax Assets, Valuation Allowance |
$83,968,000 |
USD |
0.3% |
Q4 2024 |
FY 2024 |
| Deferred Tax Assets, Gross |
$83,968,000 |
USD |
0.3% |
Q4 2024 |
FY 2024 |
| Payments to Acquire Property, Plant, and Equipment |
$0 |
USD |
|
Q1 2024 |
Q1 2024 |
| Comprehensive Income (Loss), Net of Tax, Attributable to Parent |
$10,044,000 |
USD |
22% |
Q3 2025 |
Q3 2025 |
| Deferred Tax Assets, Operating Loss Carryforwards |
$67,899,000 |
USD |
-3.2% |
Q4 2024 |
FY 2024 |
| Preferred Stock, Shares Authorized |
15,000,000 |
shares |
0% |
Q4 2024 |
FY 2024 |
| Unrecognized Tax Benefits |
$640,000 |
USD |
0% |
Q4 2024 |
FY 2024 |
| Additional Paid in Capital |
$404,540,000 |
USD |
2.6% |
Q3 2025 |
Q3 2025 |
| Preferred Stock, Shares Outstanding |
0 |
shares |
|
Q4 2024 |
FY 2024 |
| Depreciation, Depletion and Amortization |
$55,000 |
USD |
-8.3% |
Q1 2025 |
Q1 2025 |
| Share-based Payment Arrangement, Expense |
$400,000 |
USD |
300% |
Q3 2025 |
Q3 2025 |
| Interest Expense |
$422,000 |
USD |
15% |
Q1 2024 |
Q1 2024 |